Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
Maserati
R
R
Villani
P
P
Cocchi
L
L
Regazzi
M B
MB
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000097:blood / Q000493:pharmacokinetics*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D004347:Drug Interactions; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D019258:Saquinavir / Q000097:blood / Q000493:pharmacokinetics*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology*
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D017320:HIV Protease Inhibitors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D019258:Saquinavir